Akebia grants inducement stock options under Nasdaq Rule 5635(c)(4)
Akebia Therapeutics granted one newly hired employee options to purchase an aggregate of 8,400 shares of its common stock under Nasdaq Listing Rule 5635(c)(4).
CAMBRIDGE, Mass., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc.
NASDAQ:AKBA, a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 8,400 shares of Akebia’s common st…